Lupin Partners with Celnova for Drug Distribution in South America: Rediff Moneynews

[ad_1]

Lupin's subsidiary has partnered with Celnova Pharma to distribute NaMuscla, a drug for non-dystrophic myotonic disorders, in Argentina and Colombia. The partnership aims to provide innovative treatment options for patients with these rare neuromuscular disorders.

New Delhi, Sep 27 (PTI) Lupin on Friday said its subsidiary has signed a pact with Celnova Pharma for the distribution of a drug in Argentina and Colombia. The distribution pact is for a drug indicated for the treatment of non-dystrophic myotonic disorders. Lupin Atlantis Holdings SA has inked the pact with Celnova.

As per the pact, Celnova will commercialise NaMuscla in Argentina and Colombia, for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders, Lupin said in a statement.

NaMuscla is the first and the only licensed product in Europe for this indication, it added.

NDM disorders are a group of rare, inherited neuromuscular disorders, characterized by the inability to relax muscles due to voluntary contraction resulting in myotonia or muscle stiffness.

NaMuscla reduces myotonia symptoms in people with NDM, resulting in a significant improvement in quality of life and other functional and clinical outcomes for patients.

NaMuscla, which has been designated orphan drug status in Europe and US, received EU marketing authorisation in December 2018.

As per the agreement, Celnova will be the exclusive distributor of NaMuscla in Argentina and Colombia, and drive the registration, importation, storage, and sales, Lupin said.

The Mumbai-based company will manufacture and supply the finished products to Celnova, it added.

"This is aligned to our commitment of meeting the needs of NDM patients by creating tailor-made solutions for each market, working with health authorities, healthcare providers, patient advocacy groups to help patients suffering from myotonia diseases," said Fabrice Egros, President Corporate Development and Growth Markets, Lupin.

Celnova CEO Juan Marrone said the collaboration addresses a significant unmet need of those living with non-dystrophic myotonic disorders, offering an innovative treatment option that can greatly improve quality of life.

DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

[ad_1]

Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f6b9bf287140849f655939bae5929a&url=https%3A%2F%2Fmoney.rediff.com%2Fnews%2Fmarket%2Flupin-partners-with-celnova-for-drug-distribution-in-south-america%2F16346220240927&c=597001787767459322&mkt=en-us Author : Publish date : 2024-09-27 02:32:00 Copyright for syndicated content belongs to the linked Source .

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Lupin Partners with Celnova for Drug Distribution in South America: Rediff Moneynews

What to know about Hurricane Helene and widespread flooding the storm left across the Southeast US

Canada’s Top Growing Companies 2024: Activate

Canada’s Top Growing Companies 2024: Activate

Heartbreaking Tragedy Exposes Critical Failures in America’s Pedestrian Safety

Uncover the Caribbean’s Best-Kept Secret: The Island Everyone is Talking About for Its Safety!

Antigua and Barbuda Poised to Shine as the Caribbean’s Second Fastest Growing Economy!

Exciting News: Aruba Reopens Its Borders to Latin America on December 1!

Urgent Warning: US Tariffs Could Jeopardize Bahamas’ Trade and Tourism!

Barbados Welcomes a Tourism Boom as the US Overtakes the UK in Visitor Numbers for 2025!

Peak Re Launches Thrilling New Venture in North America!

Bolivia’s Political Landscape Transforms: Centrist Candidate Surges as Voters Turn Away from Socialism

Bolsonaro’s Conviction: What It Means for U.S.-Brazil Relations

Turks & Caicos Islands Triumph Over British Virgin Islands in Epic Rugby Clash!

Categories

Archives